beta-Catenin regulates vascular endothelial growth factor expression in colon cancer.
Vijay Easwaran, Wendy J. Fantl(Stanford Medicine), Lida Guo, Landon J. Inge(St. Joseph's Hospital and Medical Center), Robert N. Taylor(University at Buffalo, State University of New York), Pablo D. García, Evelyn N. Garrett, Marion Wiesmann, Vivien W. Chan(Novartis (United States)), Sang H. Lee(Gangneung–Wonju National University), Filippo Randazzo, Jaime A. Escobedo, Sharon L. Aukerman, Robert H. Gundel, Cheryl Goldbeck, John Fuller(The Royal Free Hospital), Robert S. Warren(University of California, San Francisco)
PubMed
June 15, 2003
Cited by 274
Related Papers
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
|Nature|2012|8.5k
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
|The Lancet|2004|3.8k
Vascular Risk Factors and Diabetic Neuropathy
|New England Journal of Medicine|2005|1.3k
Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes
|The Lancet|1998|743
Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis.
|Journal of Clinical Investigation|1995|698